Ye-Peng Wang

Publication Activity (10 Years)

Years Active: 2023-2023
Publications (10 Years): 3

Top Topics

Small Cell Lung Cancer

Epidermal Growth Factor Receptor

Top Venues

Expert review of anticancer therapy

This page only lists publications with an associated author ORCID identifier.

Publications

Qi-Ming Zheng, Yuan-Yuan Li, Ye-Peng Wang, Guo-Xiang Li, Meng-Meng Zhao, Zhi-Gang Sun
Association between CD8+ tumor-infiltrating lymphocytes and prognosis of non-small cell lung cancer patients treated with PD-1/PD-L1 inhibitors: a systematic review and meta-analysis. Expert review of anticancer therapy 23 (6) (2023)
Qi-Ming Zheng, Yuan-Yuan Li, Ye-Peng Wang, Guo-Xiang Li, Meng-Meng Zhao, Zhi-Gang Sun
Association between CD8+ tumor-infiltrating lymphocytes and prognosis of non-small cell lung cancer patients treated with PD-1/PD-L1 inhibitors: a systematic review and meta-analysis. Expert review of anticancer therapy (2023)
Qi-Ming Zheng, Yuan-Yuan Li, Ye-Peng Wang, Guo-Xiang Li, Meng-Meng Zhao, Zhi-Gang Sun
Association between CD8+ tumor-infiltrating lymphocytes and prognosis of non-small cell lung cancer patients treated with PD-1/PD-L1 inhibitors: a systematic review and meta-analysis. Expert review of anticancer therapy (2023)